𝛼SK or Searchbullish
Hugel (145020 KS): South Korea’s Low-Cost Botox Leader Now Expanding to the US
103 Views21 Sep 2026 11:19
On Tuesday, Meera Kapoor wrote about how GLP-1 drugs cause people's skin to become saggy – the effect that's now popularly known as "Ozempic...
What is covered in the Full Insight:
- Introduction to Hugel and Botox Industry
- Comparative Analysis: Botulax vs. BOTOX
- Hugel's International Expansion Strategy
- Challenges and Competitive Landscape
- Financial Metrics and Future Outlook
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 20-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Hugel (145020 KS): South Korea’s Low-Cost Botox Leader Now Expanding to the US21 Sep 2026
x